Bullfrog AI Holdings, Inc. Common Stock (BFRG)

USD 1.25

(-3.85%)

Market Cap (In USD)

10.89 Million

Revenue (In USD)

65 Thousand

Net Income (In USD)

-5.35 Million

Avg. Volume

863.49 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.43-8.35
PE
-1.47
EPS
-0.85
Beta Value
0.709132
ISIN
US12021E1091
CUSIP
CIK
1829247
Shares
8713152.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Vininder Singh
Employee Count
-
Website
https://www.bullfrogai.com
Ipo Date
2023-02-13
Details
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.